Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 331 publications
Evidence of Higgs Boson Inclusive Production at High Transverse Momentum Decaying to a Pair of b-Quarks with the ATLAS Detector.
Journal: Physical review letters
Published: March 24, 2026
Combination of Measurements of CP Properties of Higgs Boson Interactions with Vector Bosons Using Proton-Proton Collisions at sqrt[s]=13 TeV with the ATLAS Detector.
Journal: Physical review letters
Published: March 24, 2026
Evaluation of the GenoScreen Deeplex Myc-TB workflow for drug-resistant tuberculosis testing in South Africa.
Journal: Frontiers in public health
Published: March 19, 2026
"Six months is a lot of time to lie": Anticipated stigma, disclosure and treatment preferences among participants in a tuberculosis therapeutic trial.
Journal: Research square
Published: January 09, 2026
Unpacking bedaquiline heteroresistance: the importance of intermediate profiles for phenotypic drug susceptibility testing.
Journal: Antimicrobial agents and chemotherapy
Published: July 21, 2025
Evidence for the Dimuon Decay of the Higgs Boson in pp Collisions with the ATLAS Detector.
Journal: Physical review letters
Published: July 08, 2025
CountFU: Ditching CFUs for qPCR enumeration of Mycobacterium tuberculosis and a call to join the revolution.
Journal: Tuberculosis (Edinburgh, Scotland)
Published: July 03, 2025
Mycobacterial DNA Extraction using Bead Beating in Custom Buffer Followed by NGS Workflow.
Journal: Journal of visualized experiments : JoVE
Published: June 30, 2025
Matrix-based DNA Extraction for Targeted Next-Generation Sequencing on Decontaminated Sputum Samples.
Journal: Journal of visualized experiments : JoVE
Published: June 23, 2025
Bedaquiline resistance in patients with Xpert MTB/RIF Ultra-tested rifampicin-resistant tuberculosis in the Western Cape, South Africa: a prospective study.
Journal: The Lancet. Microbe
Published: May 20, 2025
A 3-month clofazimine-rifapentine-containing regimen for drug-susceptible tuberculosis versus standard of care (Clo-Fast): a randomised, open-label, phase 2c clinical trial.
Journal: The Lancet. Infectious diseases
Published: April 17, 2025
Last Updated: 09/26/2026